Key result
Echocardiography plays a central role in the diagnosis, symptom management, risk stratification, and treatment decisions for patients with hypertrophic cardiomyopathy.
Echocardiography plays a central role in the diagnosis, risk stratification, and management of hypertrophic cardiomyopathy.
The clinical spectrum of hypertrophic cardiomyopathy (HCM) is complex and includes a variety of phenotypes, which leads to different types of manifestations. Although most of the patients are asymptomatic, a significant proportion of them will develop symptoms or risk of arrhythmias and sudden cardiac death (SCD). Therefore, the objectives of HCM diagnosis and management are to relieve the patients' symptoms (chest pain, heart failure, syncope, palpitations, etc.), prevent disease progression and major cardiovascular complications and SCD. The heterogeneity of HCM patterns, their symptoms and assessment is a challenge for the cardiologist.
No takes yet. Share an insight, caveat, or question.
Pantazis et al. (2015) conducted a review in Hypertrophic cardiomyopathy. Echocardiography plays a central role in the diagnosis, symptom management, risk stratification, and treatment decisions for patients with hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: